Portal de Periódicos da CAPES

Complications of Thoracoabdominal Retroperitoneal Lymph Node Dissection

1982; Lippincott Williams & Wilkins; Volume: 127; Issue: 6 Linguagem: Inglês

10.1016/s0022-5347(17)54255-x

1527-3792

Donald G. Skinner, Aitan Melamub, Gary Lieskovsky,

Trauma Management and Diagnosis

No AccessJournal of Urology1 Jun 1982Complications of Thoracoabdominal Retroperitoneal Lymph Node Dissection Donald G. Skinner, Aitan Melamub, and Gary Lieskovsky Donald G. SkinnerDonald G. Skinner , Aitan MelamubAitan Melamub , and Gary LieskovskyGary Lieskovsky View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)54255-XAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail From January 1975 through May 1980, 149 consecutive patients underwent a thoracoabdominal approach to radical retroperitoneal lymph node dissection as part of the management for nonseminomatous germ cell tumors of the testis. Two patients died postoperatively, for an operative mortality rate of 1.3 per cent. Both deaths occurred in patients with massive abdominal disease and were owing to hepatic failure, with the finding of progressive metastatic disease involving the porta hepatis, and not to any complication relating to the technical aspects of the operation. There were no deaths encountered in 109 patients with stages A and B disease. Over-all, there were 12 major (8 per cent) and 7 minor (4.7 per cent) complications among the 149 patients. Of the 12 major complications 9 occurred in 52 patients with stages B3 and C disease, while only 3 of 97 patients who underwent a thoracoabdominal approach for early stage disease sustained a major complication (3.1 per cent). The average hospital stay for the entire group of 149 patients was 11.2 days: 9.6 days for the 130 patients who did not have any complication, 13.9 days for the 7 with minor complications and 26.3 days for the 12 with major complications. These data indicate that thoracoabdominal radical retroperitoneal lymph node dissection is an extremely well tolerated procedure, with low morbidity and a high degree of effectiveness in controlling primary metastatic disease. Retroperitoneal recurrence has been noted in only 1 of the 149 patients (0.7 per cent). © 1982 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited byKern S, Cary C, Kaimakliotis H, Pedrosa J, Masterson T, Bihrle R, Foster R and Kesler K (2020) Surgical Management of Retrocrural Disease in Germ Cell Tumors: Outcomes and Evolution of PracticeJournal of Urology, VOL. 205, NO. 3, (812-819), Online publication date: 1-Mar-2021.HEIDENREICH A, ALBERS P, HARTMANN M, KLIESCH S, KÖHRMANN K, KREGE S, LOSSIN P and WEISSBACH L (2018) Complications of Primary Nerve Sparing Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Experience of the German Testicular Cancer Study GroupJournal of Urology, VOL. 169, NO. 5, (1710-1714), Online publication date: 1-May-2003.BECK S, FOSTER R, BIHRLE R, KOCH M, WAHLE G and DONOHUE J (2018) AORTIC REPLACEMENT DURING POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTIONJournal of Urology, VOL. 165, NO. 5, (1517-1520), Online publication date: 1-May-2001.KAPOOR A, ZIPPE C and GILL I (2018) EMERGENCY AORTORENAL REVASCULARIZATION DURING SALVAGE RETROPERITONEAL LYMPH NODE DISSECTIONJournal of Urology, VOL. 162, NO. 4, (1377-1378), Online publication date: 1-Oct-1999.JANETSCHEK G, HOBISCH A, HITTMAIR A, HOLTL L, PESCHEL R and BARTSCH G (2018) LAPAROSCOPIC RETROPERITONEAL LYMPHADENECTOMY AFTER CHEMOTHERAPY FOR STAGE IIB NONSEMINOMATOUS TESTICULAR CARCINOMAJournal of Urology, VOL. 161, NO. 2, (477-481), Online publication date: 1-Feb-1999.NASH P, LEIBOVITCH I, FOSTER R, BIHRLE R, ROWLAND R and DONOHUE J (2018) EN BLOC NEPHRECTOMY IN PATIENTS UNDERGOING POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION FOR NONSEMINOMATOUS TESTIS CANCER: INDICATIONS, IMPLICATIONS AND OUTCOMESJournal of Urology, VOL. 159, NO. 3, (707-710), Online publication date: 1-Mar-1998.Hejase M, Donohue J, Foster R, Bihrle R, Coogan C, Rowland R and Wahle G (2018) Post-Chemotherapy Resection of Nonseminomatous Germ Cell Testicular Tumors Metastatic to the MediastinumJournal of Urology, VOL. 156, NO. 4, (1345-1348), Online publication date: 1-Oct-1996.Leibovitch I, Nash P, Little S, Foster R and Donohue J (2018) Spinal Cord Ischemia After Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell CancerJournal of Urology, VOL. 155, NO. 3, (947-951), Online publication date: 1-Mar-1996.Baniel J, Foster R, Rowland R, Bihrle R and Donohue J (2018) Original Articles: Testis Cancer: Complications of Post-Chemotherapy Retroperitoneal Lymph Node DissectionJournal of Urology, VOL. 153, NO. 3S, (976-980), Online publication date: 1-Mar-1995.Donohue J (2018) Editorial CommentsJournal of Urology, VOL. 152, NO. 4, (1191-1192), Online publication date: 1-Oct-1994.Richie J (2018) Editorial CommentsJournal of Urology, VOL. 152, NO. 4, (1191-1192), Online publication date: 1-Oct-1994.Gerber G, Bissada N, Hulbert J, Kavoussi L, Moore R, Kantoff P and Rukstalis D (2018) Laparoscopic Retroperitoneal Lymphadenectomy: Multi-Institutional AnalysisJournal of Urology, VOL. 152, NO. 4, (1188-1191), Online publication date: 1-Oct-1994.Baniel J, Foster R, Rowland R, Bihrle R and Donohue J (2018) Complications of Primary Retroperitoneal Lymph Node DissectionJournal of Urology, VOL. 152, NO. 2 Part 1, (424-427), Online publication date: 1-Aug-1994.Baniel J, Foster R, Rowland R, Bihrle R and Donohue J (2018) Management of Chylous Ascites after Retroperitoneal Lymph Node Dissection for Testicular CancerJournal of Urology, VOL. 150, NO. 5 Part 1, (1422-1424), Online publication date: 1-Nov-1993.Richie J (2018) Clinical Stage 1 Testicular Cancer: The Role of Modified Retroperitoneal LymphadenectomyJournal of Urology, VOL. 144, NO. 5, (1160-1163), Online publication date: 1-Nov-1990.Moul J, Robertson J, George S, Paulson D and Walther P (2018) Complications of Therapy for Testicular CancerJournal of Urology, VOL. 142, NO. 6, (1491-1496), Online publication date: 1-Dec-1989.Thrasher J, Horne D, Raife M and Wettlaufer J (2018) Small Bowel Intussusception: an Unusual Complication of Retroperitoneal Lymph Node DissectionJournal of Urology, VOL. 142, NO. 3, (826-827), Online publication date: 1-Sep-1989. (2018) Reply By AuthorsJournal of Urology, VOL. 134, NO. 6, (1130-1130), Online publication date: 1-Dec-1985.Donohue J (2018) Editorial CommentJournal of Urology, VOL. 134, NO. 6, (1130-1130), Online publication date: 1-Dec-1985.Logothetis C, Samuels M, Selig D, Johnson D, Swanson D and von Eschenbach A (2018) Primary Chemotherapy Followed by a Selective Retro Peritoneal Lymphadenectomy in the Management of Clinical Stage II Testicular Carcinoma: A Preliminary ReportJournal of Urology, VOL. 134, NO. 6, (1127-1130), Online publication date: 1-Dec-1985. Volume 127Issue 6June 1982Page: 1107-1110 Advertisement Copyright & Permissions© 1982 by The American Urological Association Education and Research, Inc.Metrics Author Information Donald G. Skinner More articles by this author Aitan Melamub Current address: Division of Urology, University of California, San Francisco, California 94143. More articles by this author Gary Lieskovsky More articles by this author Expand All Advertisement PDF downloadLoading ...